Eiman Yehia Ibrahim MD
Endocrinology, Obesity Medicine & Nutrition
Physician
Join to View Full Profile
3315 Berrywood DrGMEColumbia, MO 65201
Phone+1 573-882-3818
Dr. Ibrahim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Eiman Ibrahim is an internal medicine specialist located in Columbia, MO, with subspecialties in endocrinology and obesity medicine & nutrition. She completed her internal medicine residency at Quinnipiac University Frank H. Netter MD School of Medicine/St Vincent's Medical Center from 2021 to 2024 and is currently a clinical fellow at the University of Missouri. Dr. Ibrahim has published several research articles, notably on topics such as cardiovascular disease prevention in women with type 2 diabetes and PD-L1 protein expression in breast cancer. Her work has been recognized in various journals and cited multiple times by other publications.
Education & Training
Quinnipiac University Frank H. Netter MD School of Medicine/St Vincent's Medical CenterResidency, Internal Medicine, 2021 - 2024
Certifications & Licensure
MO State Medical License 2024 - 2026
CT State Medical License 2021 - 2024
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Prevention of cardiovascular disease in women with type 2 diabetes: the role of incretin mimetics and sodium-glucose cotransporter-2 inhibitors.Eiman Ibrahim, Mya Burken, Guido Lastra, Camila Manrique-Acevedo
American Journal of Physiology. Cell Physiology. 2025-01-01 - 1 citationsClonal hematopoiesis of indeterminate potential is associated with increased risk of immune checkpoint inhibitor myocarditis in a prospective study of a cardio-oncolog...Rachel Jaber Chehayeb, Jaiveer Singh, Carlos Matute-Martinez, Nathan W Chen, Ana Ferrigno Guajardo
Cardio-Oncology. 2024-11-26 - 20 citationsPredictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer.Kim R M Blenman, Michal Marczyk, Thomas Karn, Tao Qing, Xiaotong Li
Clinical Cancer Research. 2022-06-13
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
